Grufity logo
Grufity logo
BIOR

BIOR - Biora Therapeutics, Inc. Stock Price, Fair Value and News

$0.220.00 (0.00%)
Market Closed as of 27 Mar 2026, 04:00 pm ET

Price Targets

BIOR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BIOR Price Action

BIOR RSI Chart

BIOR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BIOR Valuation

Market Cap

809.1K

Price/Earnings (Trailing)

-0.03

Price/Sales (Trailing)

2.65

EV/EBITDA

0.09

Price/Free Cashflow

-0.02

BIOR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

BIOR Fundamentals

BIOR Revenue

BIOR Earnings

BIOR Profitability

Free Cashflow Yield

-5.7K%

BIOR Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
2024----
2023----
20221.2M828.0K726.0K305.0K
2021414.0K666.0K918.0K1.2M
2020113.3M73.3M36.8M162.0K
2019132.0M136.0M140.0M144.0M
2018---128.0M
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Biora Therapeutics, Inc.

BIOR
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and Systemic oral delivery platform for oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.
 CEO
 WEBSITEbioratherapeutics.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES54

Biora Therapeutics, Inc. Frequently Asked Questions

BIOR is the stock ticker symbol of Biora Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 27 2026, market cap of Biora Therapeutics, Inc. is 809.1 Thousand. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 27 2026, BIOR's PE ratio (Price to Earnings) is -0.03 and Price to Sales (PS) ratio is 2.65. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BIOR PE ratio will change depending on the future growth rate expectations of investors.